Note: Azenosertib is an investigational therapeutic and has not been approved by the FDA or any other regulatory authority. These events and presentations accessible on this website contain forward looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These statements are made only as of the date of each presentation and are subject to risks and uncertainties that could cause actual results to differ materially. For more information about forward looking statements see our website’s Terms of Use. For a discussion of risks, see the discussion under the caption “Risk Factors” in our most recently filed periodic report and subsequent filings with the SEC under SEC Filings.